Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ME Therapeutics Holdings Inc C.METX

Alternate Symbol(s):  METXF

ME Therapeutics Holdings Inc. is a Canada-based biotechnology company. The Company is involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. The Company’s lead candidate is a novel high affinity antibody drug that targets a key protein involved in the generation of suppressive myeloid cells. This antibody drug candidate is being... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:METX)

ME Therapeutics to collaborate with NanoVation Therapeutics

Jocelyn Aspa July 8, 2024

ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells

Newsfile July 8, 2024

CSE Bulletin: INDEX - CSE 25 INDEX QUARTERLY REBALANCING

Newsfile June 13, 2024

ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial

Newsfile May 29, 2024

ME Therapeutics to Present at Investor Clubhouse at the Canadian Open and Attend the 2024 BIO International Convention for Partnering Opportunities

Newsfile May 17, 2024

ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024

Newsfile April 15, 2024

ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV

Newsfile March 26, 2024

ME Therapeutics Announces Closing of Non-Brokered Private Placement

Newsfile March 6, 2024

ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update

Newsfile February 27, 2024
View More News ››

Opinion & Analysis (CSE:METX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:METX)

Be the first to post on this bullboard.

EnviroGold Global Limited.

EnviroGold Global Limited.

EnviroGold Global Limited is a Canadian headquartered clean technology company with a global vision and a strategic focus ...
View More »